Company / Working Capital per Share
Phio Pharmaceuticals Corp. Working Capital per Share History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$19.37
FY2020
5-year range
$1.21 / $19.37
FY2016-FY2020
Trend
+22.4%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has increased for 3 consecutive years, from $1.21 in FY2017 to $19.37 in FY2020.
Based on SEC 10-K filings.
19.37 in FY2020 with a 3-year CAGR of +152.4%.
Improved from $5.52 to $19.37 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +152.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Phio Pharmaceuticals Corp.'s working capital per share has grown for 3 consecutive years.
- In FY2020, working capital per share increased 22.4% year-over-year.
- Lowest working capital per share in the period was in FY2012.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $19.37 | +22.4% |
| FY2019 | $15.82 | +186.8% |
| FY2018 | $5.52 | +357.8% |
| FY2017 | $1.21 | -25.5% |
| FY2016 | $1.62 | -32.5% |
| FY2013 | $2.39 | +6378.6% |
| FY2012 | $0.04 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026